{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:18:13Z","timestamp":1790187493911,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["#RF-2011-02351193"],"award-info":[{"award-number":["#RF-2011-02351193"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00415-020-09838-9","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T12:02:41Z","timestamp":1587211361000},"page":"2272-2280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease"],"prefix":"10.1007","volume":"267","author":[{"given":"Yuri Matteo","family":"Falzone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuta","family":"Domi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Agosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paride","family":"Schito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaldo","family":"Del Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Comola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Leocani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Quattrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilo","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,18]]},"reference":[{"issue":"6","key":"9838_CR1","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00415-016-8091-6","volume":"263","author":"N Riva","year":"2016","unstructured":"Riva N, Agosta F, Lunetta C, Filippi M, Quattrini A (2016) Recent advances in amyotrophic lateral sclerosis. J Neurol 263(6):1241\u20131254. https:\/\/doi.org\/10.1007\/s00415-016-8091-6","journal-title":"J Neurol"},{"key":"9838_CR2","doi-asserted-by":"publisher","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17085","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"9838_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","volume":"82","author":"A Chio","year":"2011","unstructured":"Chio A, Calvo A, Moglia C, Mazzini L, Mora G, Group Ps (2011) Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82(7):740\u2013746. https:\/\/doi.org\/10.1136\/jnnp.2010.235952","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"9838_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jnnp-2013-307223","volume":"86","author":"A Montuschi","year":"2015","unstructured":"Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S, Canosa A, Chio A (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168\u2013173. https:\/\/doi.org\/10.1136\/jnnp-2013-307223","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"9838_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/cge.12973","volume":"92","author":"EP McCann","year":"2017","unstructured":"McCann EP, Williams KL, Fifita JA, Tarr IS, O'Connor J, Rowe DB, Nicholson GA, Blair IP (2017) The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clin Genet 92(3):259\u2013266. https:\/\/doi.org\/10.1111\/cge.12973","journal-title":"Clin Genet"},{"issue":"10","key":"9838_CR6","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1212\/WNL.0000000000003067","volume":"87","author":"ME Umoh","year":"2016","unstructured":"Umoh ME, Fournier C, Li Y, Polak M, Shaw L, Landers JE, Hu W, Gearing M, Glass JD (2016) Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology 87(10):1024\u20131030. https:\/\/doi.org\/10.1212\/WNL.0000000000003067","journal-title":"Neurology"},{"issue":"12","key":"9838_CR7","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1136\/jnnp-2015-312908","volume":"87","author":"JA Knibb","year":"2016","unstructured":"Knibb JA, Keren N, Kulka A, Leigh PN, Martin S, Shaw CE, Tsuda M, Al-Chalabi A (2016) A clinical tool for predicting survival in ALS. J Neurol Neurosurg Psychiatry 87(12):1361\u20131367. https:\/\/doi.org\/10.1136\/jnnp-2015-312908","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"9838_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","volume":"17","author":"HJ Westeneng","year":"2018","unstructured":"Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt J, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Korner S, Ringer TM, Rodiger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chio A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17(5):423\u2013433. https:\/\/doi.org\/10.1016\/S1474-4422(18)30089-9","journal-title":"Lancet Neurol"},{"key":"9838_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fneur.2018.00726","volume":"9","author":"DW Li","year":"2018","unstructured":"Li DW, Ren H, Jeromin A, Liu M, Shen D, Tai H, Ding Q, Li X, Cui L (2018) Diagnostic performance of neurofilaments in Chinese patients with amyotrophic lateral sclerosis: a prospective study. Front Neurol 9:726. https:\/\/doi.org\/10.3389\/fneur.2018.00726","journal-title":"Front Neurol"},{"issue":"1","key":"9838_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jnnp-2015-311387","volume":"87","author":"P Steinacker","year":"2016","unstructured":"Steinacker P, Feneberg E, Weishaupt J, Brettschneider J, Tumani H, Andersen PM, von Arnim CA, Bohm S, Kassubek J, Kubisch C, Lule D, Muller HP, Muche R, Pinkhardt E, Oeckl P, Rosenbohm A, Anderl-Straub S, Volk AE, Weydt P, Ludolph AC, Otto M (2016) Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry 87(1):12\u201320. https:\/\/doi.org\/10.1136\/jnnp-2015-311387","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"9838_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14737175.2018.1530987","volume":"18","author":"A Taga","year":"2018","unstructured":"Taga A, Maragakis NJ (2018) Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Rev Neurother 18(11):871\u2013886. https:\/\/doi.org\/10.1080\/14737175.2018.1530987","journal-title":"Expert Rev Neurother"},{"key":"9838_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fneur.2019.00291","volume":"10","author":"NS Verber","year":"2019","unstructured":"Verber NS, Shepheard SR, Sassani M, McDonough HE, Moore SA, Alix JJP, Wilkinson ID, Jenkins TM, Shaw PJ (2019) Biomarkers in motor neuron disease: a state of the art review. Front Neurol 10:291. https:\/\/doi.org\/10.3389\/fneur.2019.00291","journal-title":"Front Neurol"},{"issue":"1","key":"9838_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbadis.2013.10.013","volume":"1842","author":"A Conti","year":"2014","unstructured":"Conti A, Riva N, Pesca M, Iannaccone S, Cannistraci CV, Corbo M, Previtali SC, Quattrini A, Alessio M (2014) Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients. Biochim Biophys Acta 1842(1):99\u2013106. https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.013","journal-title":"Biochim Biophys Acta"},{"key":"9838_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","volume":"9","author":"K Poesen","year":"2018","unstructured":"Poesen K, Van Damme P (2018) Diagnostic and prognostic performance of neurofilaments in ALS. Front Neurol 9:1167. https:\/\/doi.org\/10.3389\/fneur.2018.01167","journal-title":"Front Neurol"},{"issue":"2","key":"9838_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.neuron.2016.07.007","volume":"91","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu M, Maia LF, Preische O, Schelle J, Apel A, Kaeser SA, Schweighauser M, Eninger T, Lambert M, Pilotto A, Shimshek DR, Neumann U, Kahle PJ, Staufenbiel M, Neumann M, Maetzler W, Kuhle J, Jucker M (2016) Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron 91(2):494\u2013496. https:\/\/doi.org\/10.1016\/j.neuron.2016.07.007","journal-title":"Neuron"},{"issue":"4","key":"9838_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","volume":"89","author":"M De Schaepdryver","year":"2018","unstructured":"De Schaepdryver M, Jeromin A, Gille B, Claeys KG, Herbst V, Brix B, Van Damme P, Poesen K (2018) Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 89(4):367\u2013373. https:\/\/doi.org\/10.1136\/jnnp-2017-316605","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"9838_CR17","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen K, De Schaepdryver M, Stubendorff B, Gille B, Muckova P, Wendler S, Prell T, Ringer TM, Rhode H, Stevens O, Claeys KG, Couwelier G, D'Hondt A, Lamaire N, Tilkin P, Van Reijen D, Gourmaud S, Fedtke N, Heiling B, Rumpel M, Rodiger A, Gunkel A, Witte OW, Paquet C, Vandenberghe R, Grosskreutz J, Van Damme P (2017) Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88(24):2302\u20132309. https:\/\/doi.org\/10.1212\/WNL.0000000000004029","journal-title":"Neurology"},{"issue":"3","key":"9838_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/nan.12511","volume":"45","author":"B Gille","year":"2019","unstructured":"Gille B, De Schaepdryver M, Goossens J, Dedeene L, De Vocht J, Oldoni E, Goris A, Van Den Bosch L, Depreitere B, Claeys KG, Tournoy J, Van Damme P, Poesen K (2019) Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. Neuropathol Appl Neurobiol 45(3):291\u2013304. https:\/\/doi.org\/10.1111\/nan.12511","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"9838_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnnp-2012-303768s","volume":"84","author":"KB Boylan","year":"2013","unstructured":"Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, Johnston A, Overstreet K, Kelly C, Polak M, Shaw G (2013) Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 84(4):467\u2013472. https:\/\/doi.org\/10.1136\/jnnp-2012-303768s","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"9838_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/jnnp-2014-307672","volume":"86","author":"CH Lu","year":"2015","unstructured":"Lu CH, Petzold A, Topping J, Allen K, Macdonald-Wallis C, Clarke J, Pearce N, Kuhle J, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Greensmith L, Malaspina A (2015) Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. J Neurol Neurosurg Psychiatry 86(5):565\u2013573. https:\/\/doi.org\/10.1136\/jnnp-2014-307672","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"9838_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","volume":"74","author":"A Gaiani","year":"2017","unstructured":"Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Soraru G (2017) Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease. JAMA Neurol 74(5):525\u2013532. https:\/\/doi.org\/10.1001\/jamaneurol.2016.5398","journal-title":"JAMA Neurol"},{"issue":"22","key":"9838_CR22","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"CH Lu","year":"2015","unstructured":"Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, Turner MR, Malaspina A (2015) Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology 84(22):2247\u20132257. https:\/\/doi.org\/10.1212\/WNL.0000000000001642","journal-title":"Neurology"},{"issue":"1","key":"9838_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00415-016-8313-y","volume":"264","author":"A Calvo","year":"2017","unstructured":"Calvo A, Moglia C, Lunetta C, Marinou K, Ticozzi N, Ferrante GD, Scialo C, Soraru G, Trojsi F, Conte A, Falzone YM, Tortelli R, Russo M, Chio A, Sansone VA, Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Monsurro MR, Sabatelli M, Riva N, Logroscino G, Messina S, Fini N, Mandrioli J (2017) Factors predicting survival in ALS: a multicenter Italian study. J Neurol 264(1):54\u201363. https:\/\/doi.org\/10.1007\/s00415-016-8313-y","journal-title":"J Neurol"},{"issue":"5","key":"9838_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293\u2013299","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"1","key":"9838_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.22380","volume":"70","author":"M Schrooten","year":"2011","unstructured":"Schrooten M, Smetcoren C, Robberecht W, Van Damme P (2011) Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol 70(1):79\u201383. https:\/\/doi.org\/10.1002\/ana.22380","journal-title":"Ann Neurol"},{"issue":"2","key":"9838_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1474-4422(18)30406-X","volume":"18","author":"N Riva","year":"2019","unstructured":"Riva N, Mora G, Soraru G, Lunetta C, Ferraro OE, Falzone Y, Leocani L, Fazio R, Comola M, Comi G (2019) Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol 18(2):155\u2013164. https:\/\/doi.org\/10.1016\/S1474-4422(18)30406-X","journal-title":"Lancet Neurol"},{"issue":"Pt 3","key":"9838_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/brain\/awr351","volume":"135","author":"JC Roche","year":"2012","unstructured":"Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Wijesekera L, Turner MR, Leigh PN, Shaw CE, Al-Chalabi A (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135(Pt 3):847\u2013852. https:\/\/doi.org\/10.1093\/brain\/awr351","journal-title":"Brain"},{"issue":"1\u20132","key":"9838_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/21678421.2013.805784","volume":"15","author":"S Abrahams","year":"2014","unstructured":"Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15(1\u20132):9\u201314. https:\/\/doi.org\/10.3109\/21678421.2013.805784","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"Pt 9","key":"9838_CR29","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(Pt 9):2456\u20132477. https:\/\/doi.org\/10.1093\/brain\/awr179","journal-title":"Brain"},{"issue":"3\u20134","key":"9838_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, HortobaGyi T, Rosenfeld J, Silani V, Ince PG, Turner MR (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18(3\u20134):153\u2013174. https:\/\/doi.org\/10.1080\/21678421.2016.1267768","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"8","key":"9838_CR31","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.clinph.2011.12.013","volume":"123","author":"N Riva","year":"2012","unstructured":"Riva N, Falini A, Inuggi A, Gonzalez-Rosa JJ, Amadio S, Cerri F, Fazio R, Del Carro U, Comola M, Comi G, Leocani L (2012) Cortical activation to voluntary movement in amyotrophic lateral sclerosis is related to corticospinal damage: electrophysiological evidence. Clin Neurophysiol 123(8):1586\u20131592. https:\/\/doi.org\/10.1016\/j.clinph.2011.12.013","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"9838_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14660820410020600","volume":"6","author":"M de Carvalho","year":"2005","unstructured":"de Carvalho M, Chio A, Dengler R, Hecht M, Weber M, Swash M (2005) Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord 6(1):17\u201328. https:\/\/doi.org\/10.1080\/14660820410020600","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"1","key":"9838_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.24980","volume":"82","author":"TF Gendron","year":"2017","unstructured":"Gendron TF, Group CONS, Daughrity LM, Heckman MG, Diehl NN, Wuu J, Miller TM, Pastor P, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Benatar M, Silani V, Glass JD, Floeter MK, Jeromin A, Boylan KB, Petrucelli L (2017) Phosphorylated neurofilament heavy chain: a biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis. Ann. Neurol 82(1):139\u2013146. https:\/\/doi.org\/10.1002\/ana.24980","journal-title":"Ann. Neurol"},{"key":"9838_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neurobiolaging.2017.05.024","volume":"57","author":"F Agosta","year":"2017","unstructured":"Agosta F, Ferraro PM, Riva N, Spinelli EG, Domi T, Carrera P, Copetti M, Falzone Y, Ferrari M, Lunetta C, Comi G, Falini A, Quattrini A, Filippi M (2017) Structural and functional brain signatures of C9orf72 in motor neuron disease. Neurobiol Aging 57:206\u2013219. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.05.024","journal-title":"Neurobiol Aging"},{"issue":"7","key":"9838_CR35","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/acn3.212","volume":"2","author":"RA Menke","year":"2015","unstructured":"Menke RA, Gray E, Lu CH, Kuhle J, Talbot K, Malaspina A, Turner MR (2015) CSF neurofilament light chain reflects corticospinal tract degeneration in ALS. Ann Clin Transl Neurol 2(7):748\u2013755. https:\/\/doi.org\/10.1002\/acn3.212","journal-title":"Ann Clin Transl Neurol"},{"key":"9838_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14063","author":"E Thouvenot","year":"2019","unstructured":"Thouvenot E, Demattei C, Lehmann S, Maceski-Maleska A, Hirtz C, Juntas-Morales R, Pageot N, Esselin F, Alphandery S, Vincent T, Camu W (2019) Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.14063","journal-title":"Eur J Neurol"},{"key":"9838_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jns.2016.05.062","volume":"367","author":"S Li","year":"2016","unstructured":"Li S, Ren Y, Zhu W, Yang F, Zhang X, Huang X (2016) Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis. J Neurol Sci 367:269\u2013274. https:\/\/doi.org\/10.1016\/j.jns.2016.05.062","journal-title":"J Neurol Sci"},{"issue":"3","key":"9838_CR38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","volume":"117","author":"J Ganesalingam","year":"2011","unstructured":"Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R (2011) Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem 117(3):528\u2013537. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07224.x","journal-title":"J Neurochem"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09838-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09838-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09838-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T06:18:46Z","timestamp":1744093126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09838-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,18]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["9838"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09838-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,18]]},"assertion":[{"value":"23 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Informed consent was obtained from the patients who participated in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The study was approved by the appropriate ethics committee and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}